Gemfibrozil methyl ester Impurity
| Product Name | Gemfibrozil methyl ester Impurity |
|---|---|
| Alternate Names | Gemfibrozil Impurities, Impurities of Gemfibrozil |
| CAT No. | CS-K-00230 |
| CAS No. | 149105-25-9 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 264.36 g/mol |
| Mol. For. | C₁₆H₂₄O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Gemfibrozil |
| Smileys | CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)OC |
| Canonical Smiles | CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)OC |
| InchIKey | YKCQSETYDHFYFZ-UHFFFAOYSA-N |
| Inchl | InChI=1S/C16H24O3/c1-12-7-8-13(2)14(11-12)19-10-6-9-16(3,4)15(17)18-5/h7-8,11H,6,9-10H2,1-5H3 |
| IUPAC | methyl 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Gemfibrozil is a drug that is commonly used to lower cholesterol levels in the body. It is a fibrate class drug, which works by activating the peroxisome proliferator-activated receptor alpha (PPARα) in the liver. The activation of PPARα results in an increase in the expression of enzymes involved in the metabolism of lipids, leading to a decrease in the levels of triglycerides and cholesterol in the blood. Gemfibrozil methyl ester impurity is a byproduct of the synthesis of Gemfibrozil.
Chemically, Gemfibrozil methyl ester impurity is a derivative of gemfibrozil, with the addition of a methyl ester functional group. The presence of this impurity in gemfibrozil can affect the quality and purity of the drug. Therefore, it is important to monitor and control the levels of this impurity during the production of gemfibrozil.
Gemfibrozil methyl ester impurity has no known therapeutic effects and can potentially cause adverse effects in patients. Therefore, it is necessary to ensure that the levels of this impurity in gemfibrozil are within the acceptable limits set by regulatory agencies. The chemical information and usage of this impurity are important for pharmaceutical manufacturers to ensure the safety and efficacy of gemfibrozil.
Get an Instant Quote
Related Compounds
iso-Gemfibrozil |